Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02111525 · ClinicalTrials.gov registry record
Fluid Status of Outpatients With Dyspnea
A clinical trial, sponsored by Intersection Medical.
- Completed
- Registry status
- 156
- Enrollment target
NCT02111525: Completed study, sponsored by Intersection Medical.
NCT02111525 is a clinical trial that has completed, run by Intersection Medical. The registered enrollment target is 156 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02111525 has completed, sponsored by Intersection Medical.
- COMPLETED
- Registry status
- 156 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the distribution of lung fluid status as reported by the IMED-4 system in patients presenting to the emergency department or urgent care facility with shortness of breath.
Primary Outcome
The IMED 4 is a new device designed to measure the lung fluid status by assessing how wet or dry the lungs are
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-10 |
What the finished NCT02111525 record still lists
NCT02111525 is an observational study that tracks outcomes without assigning an intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02111525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02111525 about?
NCT02111525 is a clinical study titled "Fluid Status of Outpatients With Dyspnea". The purpose of this study is to determine the distribution of lung fluid status as reported by the IMED-4 system in patients presenting to the emergency department or urgent care facility with shortness of breath.
What is the current status of trial NCT02111525?
This trial is currently completed. The enrollment target is 156 participants. The study started on 2014-06. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT02111525?
This trial is sponsored by Intersection Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia